Tokyo, Japan

Takaaki Hirotsu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Fukuoka, JP (2023)
  • Tokyo, JP (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Takaaki Hirotsu: Innovator in Cancer Detection

Introduction

Takaaki Hirotsu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer detection and treatment monitoring. With a total of 5 patents, Hirotsu's work focuses on innovative methods that enhance the accuracy of cancer diagnostics.

Latest Patents

Hirotsu's latest patents include a method for predicting therapeutic effects and monitoring recurrence in cancer patients. This invention provides a novel approach to detecting the therapeutic effect of cancer treatment by measuring nematode tactic behavior in response to urine samples from patients. The method involves comparing pre-treatment and post-treatment urine samples to determine the effectiveness of the treatment. Another significant patent is a method for detecting kidney cancer, which allows for highly sensitive and specific detection through the analysis of diluted urine samples and nematode attraction behavior.

Career Highlights

Throughout his career, Takaaki Hirotsu has worked with notable organizations such as Hirotsu Bio Science Inc. and Nanpuh Hospital. His experience in these institutions has allowed him to develop and refine his innovative methods for cancer detection.

Collaborations

Hirotsu has collaborated with esteemed colleagues, including Takayuki Uozumi and Satoru Kaifuchi. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Takaaki Hirotsu is a key figure in the field of cancer detection, with a focus on innovative methods that improve patient outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…